Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The enzymes involved in the phosphatidylcholine (PC) biosynthesis pathway, primarily the CDP-choline (Kennedy) pathway, are critical for membrane biogenesis, lipid signaling, and cellular homeostasis. Key enzymes include Choline Kinase (CK), CTP:Phosphocholine Cytidylyltransferase (CCT), and Choline/Ethanolamine Phosphotransferase (CEPT). These enzymes catalyze the synthesis of PC from choline, CTP, and diacylglycerol (DAG). Dysregulation of this pathway is implicated in various diseases, including cancer and metabolic disorders. Alternate pathways exist, such as PEMT mediated conversion of phosphatidylethanolamine to phosphatidylcholine.
Varies depending on specific enzyme; inhibition or activation of enzymatic activity.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphatidylcholine Biosynthesis Pathway Enzymes (PC Biosynthesis Enzymes).